British Medical Bulletin 48:912-930 (1992)
© 1992 The British Council
research-article |
Microbiology of lung infection in cystic fibrosis
Department of Medical Microbiology, Medical School, University of Edinburgh Edinburgh, UK
Abstract
Bronchopulmonary infection in cystic fibrosis (CF) patients is associated with chronic progressive lung disease and episodes of acute exacerbation. Infection is predominantly caused by bacteria, although infections with viruses, mycoplasma and fungi may play undervalued roles. Bacteria commonly isolated from CF sputum include Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa. Colonisation of the airways by mucoid, alginate-producing variants of P. aeruginosa is recognised as a major cause of pulmonary deterioration. In addition, there is now considerable concern relating to the clinical consequences of colonisation and cross-infection with P. cepacia. This review discusses the microbiology of CF focussing on the pathogenesis and epidemiology of P. aeruginosa and P. cepacia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
I Kukavica-Ibrulj and R C Levesque Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies Lab Anim, October 1, 2008; 42(4): 389 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. McNamara and R. A. Proctor Bacterial Interactions and the Microevolution of Cytochrome bd: Implications for Pathogenesis J. Bacteriol., December 1, 2006; 188(23): 7997 - 7998. [Full Text] [PDF] |
||||
![]() |
T. M. Jarry and A. L. Cheung Staphylococcus aureus Escapes More Efficiently from the Phagosome of a Cystic Fibrosis Bronchial Epithelial Cell Line than from Its Normal Counterpart. Infect. Immun., May 1, 2006; 74(5): 2568 - 2577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Phaff, H. A. W. M. Tiddens, H. A. Verbrugh, and A. Ott Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis J. Antimicrob. Chemother., April 1, 2006; 57(4): 741 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bakkevig, H. Sletta, M. Gimmestad, R. Aune, H. Ertesvag, K. Degnes, B. E. Christensen, T. E. Ellingsen, and S. Valla Role of the Pseudomonas fluorescens Alginate Lyase (AlgL) in Clearing the Periplasm of Alginates Not Exported to the Extracellular Environment J. Bacteriol., December 15, 2005; 187(24): 8375 - 8384. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Silo-Suh, S.-J. Suh, P. V. Phibbs, and D. E. Ohman Adaptations of Pseudomonas aeruginosa to the Cystic Fibrosis Lung Environment Can Include Deregulation of zwf, Encoding Glucose-6-Phosphate Dehydrogenase J. Bacteriol., November 15, 2005; 187(22): 7561 - 7568. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. McMichael, A. I. Maxwell, K. Hayashi, K. Taylor, W. A. Wallace, J. R. Govan, J. R. Dorin, and J.-M. Sallenave Antimicrobial Activity of Murine Lung Cells against Staphylococcus aureus Is Increased In Vitro and In Vivo after Elafin Gene Transfer Infect. Immun., June 1, 2005; 73(6): 3609 - 3617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Foweraker, C. R. Laughton, D. F. J. Brown, and D. Bilton Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing J. Antimicrob. Chemother., June 1, 2005; 55(6): 921 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Zaas, M. J. Duncan, G. Li, J. R. Wright, and S. N. Abraham Pseudomonas Invasion of Type I Pneumocytes Is Dependent on the Expression and Phosphorylation of Caveolin-2 J. Biol. Chem., February 11, 2005; 280(6): 4864 - 4872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Jones, M. E. Dodd, J. R. W. Govan, C. J. Doherty, C. M. Smith, B. J. Isalska, and A. K. Webb Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 257 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Morales, L. Wiehlmann, P. Gudowius, C. van Delden, B. Tummler, J. L. Martinez, and F. Rojo Structure of Pseudomonas aeruginosa Populations Analyzed by Single Nucleotide Polymorphism and Pulsed-Field Gel Electrophoresis Genotyping J. Bacteriol., July 1, 2004; 186(13): 4228 - 4237. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Saiman and J. Siegel Infection Control in Cystic Fibrosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 57 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimomura, M. Matsuura, S. Saito, Y. Hirai, Y. Isshiki, and K. Kawahara Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B Infect. Immun., September 1, 2003; 71(9): 5225 - 5230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Smith, S. B. Fiel, N. Mayer-Hamblett, B. Ramsey, and J. L. Burns Susceptibility Testing of Pseudomonas aeruginosa Isolates and Clinical Response to Parenteral Antibiotic Administration: Lack of Association in Cystic Fibrosis Chest, May 1, 2003; 123(5): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Silo-Suh, S.-J. Suh, P. A. Sokol, and D. E. Ohman A simple alfalfa seedling infection model for Pseudomonas aeruginosa strains associated with cystic fibrosis shows AlgT (sigma-22) and RhlR contribute to pathogenesis PNAS, November 26, 2002; 99(24): 15699 - 15704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Prunier, B. Malbruny, D. Tande, B. Picard, and R. Leclercq Clinical Isolates of Staphylococcus aureus with Ribosomal Mutations Conferring Resistance to Macrolides Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3054 - 3056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Lyczak, C. L. Cannon, and G. B. Pier Lung Infections Associated with Cystic Fibrosis Clin. Microbiol. Rev., April 1, 2002; 15(2): 194 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. McMorran, J. S. Palmer, D. P. Lunn, D. Oceandy, E. O. Costelloe, G. R. Thomas, D. A. Hume, and B. J. Wainwright G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L740 - L747. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimomura, M. Matsuura, S. Saito, Y. Hirai, Y. Isshiki, and K. Kawahara Lipopolysaccharide of Burkholderia cepacia and Its Unique Character To Stimulate Murine Macrophages with Relative Lack of Interleukin-1{beta}-Inducing Ability Infect. Immun., June 1, 2001; 69(6): 3663 - 3669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Smalley, P. Charalabous, A. J. Birss, and C. A. Hart Detection of Heme-Binding Proteins in Epidemic Strains of Burkholderia cepacia Clin. Vaccine Immunol., May 1, 2001; 8(3): 509 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hayashida, K. S. Harrod, and J. A. Whitsett Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L452 - L459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamath, M. L. Chen, and A. M. Chakrabarty Secretion of Nucleoside Diphosphate Kinase by Mucoid Pseudomonas aeruginosa 8821: Involvement of a Carboxy-Terminal Motif in Secretion J. Bacteriol., July 1, 2000; 182(13): 3826 - 3831. [Abstract] [Full Text] |
||||
![]() |
D. W. Martin and C. D. Mohr Invasion and Intracellular Survival of Burkholderia cepacia Infect. Immun., January 1, 2000; 68(1): 24 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Shreve, S. Butler, H. J. Kaplowitz, H. R. Rabin, D. Stokes, M. Light, W. E. Regelmann, and Investigators for the Epidemiologic Study of Cysti Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis J. Clin. Microbiol., March 1, 1999; 37(3): 753 - 757. [Abstract] [Full Text] |
||||
![]() |
S. M. Zughaier, H. C. Ryley, and S. K. Jackson Lipopolysaccharide (LPS) from Burkholderia cepacia Is More Active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in Stimulating Tumor Necrosis Factor Alpha from Human Monocytes Infect. Immun., March 1, 1999; 67(3): 1505 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zughaier, H. C. Ryley, and S. K. Jackson A Melanin Pigment Purified from an Epidemic Strain of Burkholderia cepacia Attenuates Monocyte Respiratory Burst Activity by Scavenging Superoxide Anion Infect. Immun., February 1, 1999; 67(2): 908 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, M. Hanes, C. E. Chrisp, J. C. Boucher, and V. Deretic Microbial Pathogenesis in Cystic Fibrosis: Pulmonary Clearance of Mucoid Pseudomonas aeruginosa and Inflammation in a Mouse Model of Repeated Respiratory Challenge Infect. Immun., January 1, 1998; 66(1): 280 - 288. [Abstract] [Full Text] [PDF] |
||||












